NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...
Experiments suggests H9N2 has adapted to human cells, but cases of person-to-person transmission haven’t been reported yet ...
China's GDIIST research institute has announced the development and soon release of the BIE-1, an AI supercomputer inspired ...
Scientists found a virus-like living entity in human bodies named "obelisks" - small loops of RNA, each a thousand genetic ...
NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
Experiments suggests H9N2 has adapted to human cells but cases of person-to-person transmission haven’t been reported yet.
Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge ...
Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge ...
Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge and trigger a new outbreak years later. How do they survive? And how can ...
Island Pharma aims to turn Galidesivir, its antiviral ace against Marburg, into reality – with the FDA’s November call to ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...